Clinical trial Recruiting at 1 site Observational Ages 40 to 75

Predicting who improves after phase II cardiac rehabilitation for reduced ejection fraction

Official title: Prédiction Des réponses du Patient Porteur d'Une Insuffisance Cardiaque à Fraction d'éjection altérée à Une Phase II de réadaptation Cardiaque

Run by Centre Hospitalier de Corbie · NCT07164911 · Data updated 2026-11-12

This project will test whether blood microRNA patterns together with non-invasive exercise measurements can predict which people with reduced ejection fraction heart failure will improve their peak oxygen uptake after a phase II cardiac rehab program.

Quick facts

Study typeObservational
Ages40 Years to 75 Years
SexAll
Enrollment62 (estimated)
SponsorCentre Hospitalier de Corbie
Government
Locations1 site (Corbie)
StatusRecruiting
StartedNovember 25, 2025
Main results expectedOctober 31, 2027
Study endsNovember 30, 2027
Registry record updatedDecember 16, 2025
Trial IDNCT07164911 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with HFrEF (LVEF <40%), NYHA class II or higher, clinically stable and on optimized medical therapy for at least 6 weeks, prescribed phase II cardiac rehabilitation, BMI 20–30 kg/m², sedentary or untrained, able to give informed consent and affiliated with the French national health insurance system.

Probably not a fit

Patients with contraindications to adapted physical activity, uncontrolled hypertension, significant secondary respiratory or cardiovascular disease, those outside the BMI or stability criteria, pregnant or breastfeeding individuals, or those unable to attend the center are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, single-center cohort of 62 patients with heart failure with reduced ejection fraction (LVEF <40%) who will complete a phase II exercise-based cardiac rehabilitation program. Researchers will measure peak oxygen uptake (VO2peak), cardiac hemodynamics, cerebral and muscle oxygenation during cardiopulmonary exercise testing, and circulating microRNA levels before and after the program. Participants will also perform a force–velocity test to guide individualized resistance training. The study links physiological exercise responses to molecular markers to identify predictors of improvement in ΔVO2peak.

Why it matters

Potential benefit: If successful, the findings could help personalize cardiac rehabilitation so clinicians can target the component(s) of oxygen delivery or utilization most likely to improve each patient’s exercise capacity.

How similar studies have gone: Exercise-based cardiac rehabilitation is known to improve VO2peak for many patients with HFrEF, but using circulating microRNAs to predict individual responses is a relatively novel approach that is not yet established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Heart failure with reduced ejection fraction \< 40%
* NYHA functional class ≥ II
* Clinically stable for at least 6 weeks
* On optimized medical therapy for at least 6 weeks
* Prescription for phase II cardiac rehabilitation
* BMI between 20-30 kg·m-²
* Physical activity level: sedentary or physically active but untrained
* Signed informed consent to participate in the study
* Affiliation to the French national health insurance system

Exclusion Criteria:

* Contraindication to regular adapted physical activity
* Uncontrolled arterial hypertension
* Secondary respiratory disease such as emphysema or chronic obstructive pulmonary disease (COPD)
* Secondary cardiovascular disease
* Individuals under legal protection or deprived of liberty
* Pregnant or breastfeeding women

Where it's running

  • Hospital center of Corbie
    Corbie, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.